The IL-1? inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results.
from Top Health News – ScienceDaily http://ift.tt/2wT04cW
from Tumblr http://ift.tt/2xoGkf1
No comments:
Post a Comment